Effectiveness of a change in reperfusion strategy to primary percutaneous coronary intervention in a nonselected population

Canadian Journal of Cardiology

Volumn 25, Issue 8, 2009, Pages

  Matteau, Alexis ^a   Dorais, Marc ^a   Rinfret, Stéphane ^b,c   LeLorier, Jacques ^a   Reeves, François ^a,d  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b LAVAL UNIVERSITY   (Canada)

^c UNIVERSITÉ LAVAL   (Canada)

^d CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Angioplasty; Health outcomes; Myocardial infarction; Reperfusion

Indexed keywords

ABCIXIMAB; ALTEPLASE; EPTIFIBATIDE; RETEPLASE; STREPTOKINASE; THIENOPYRIDINE DERIVATIVE; TIROFIBAN;

ADULT; AGE DISTRIBUTION; ARTICLE; CANADA; CLINICAL EFFECTIVENESS; CLINICAL PROTOCOL; CONTROLLED STUDY; CORONARY REPERFUSION; FEMALE; FIBRINOLYSIS; GASTROINTESTINAL HEMORRHAGE; HEART CATHETERIZATION; HEART INFARCTION; HEART REINFARCTION; HOSPITAL PATIENT; HUMAN; HYPERTENSION; INCIDENCE; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; ST SEGMENT ELEVATION; STROKE;

EID: 68949091803     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0828-282X(09)70124-2     Document Type: Article

References (20)

1. The Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO IIb) Angioplasty Substudy Investigators. A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction. N Engl J Med 1997;336:1621-8.
2. Schomig A, Kastrati A, Dirschinger J, et al. Coronary stenting plus platelet glycoprotein IIb/IIIa blockade compared with tissue plasminogen activator in acute myocardial infarction. N Engl J Med 2000;343:385-91.
3. Le May MR, Labinaz M, Davies RF, et al. Stenting versus thrombolysis in acute myocardial infarction trial (STAT). J Am Coll Cardiol 2001;37:985-91.
4. Bonnefoy E, Lapostolle F, Leizorovicz A, et al. Primary angioplasty versus prehospital fibrinolysis in acute myocardial infarction: A randomised study. Lancet 2002;360:825-9.
5. Kastrati A, Mehilli J, Dirschinger J, et al. Myocardial salvage after coronary stenting plus abciximab versus fibrinolysis plus abciximab in patients with acute myocardial infarction: A randomised trial. Lancet 2002;359:920-5.
6. Aversano T, Aversano LT, Passamani E, et al; Atlantic Cardiovascular Patient Outcomes Research Team (C-PORT). Thrombolytic therapy vs primary percutaneous coronary intervention for myocardial infarction in patients presenting to hospitals without on-site cardiac surgery: A randomized controlled trial. JAMA 2002;287:1943-51.
7. Andersen HR, Nielsen TT, Rasmussen K, et al; DANAMI-2 Investigators. A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. N Engl J Med 2003;349:733-42.
8. Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: A quantitative review of 23 randomised trials. Lancet 2003;361:13-20.
9. Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction - executive summary: A report of the ACC/AHA Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines on the Management of Patients With Acute Myocardial Infarction). J Am Coll Cardiol 2004;44:671-719.
10. Cannon CP, Gibson CM, Lambrew CT et al. Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction. JAMA 2000;283:2941-7.
11. Huynh T, O'Loughlin J, Joseph L, et al. Delays to reperfusion therapy in acute ST-segment elevation myocardial infarction: Results from the AMI-QUEBEC Study. CMAJ 2006;175:1527-32.
12. Zipes DP, Libby P, Bonow RO, Braunwald E. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine, 7th edn. Philadelphia: Elsevier Saunders, 2005:1141-66.
13. Gibson CM, Karha J, Murphy SA, et al. Early and longterm clinical outcomes associated with reinfarction following Fibrinolytic administration in the Thrombolysis In Myocardial Infarction Trials. J Am Coll Cardiol 2003;42:7-16.
14. Kauf TL, Velazquez EJ, Crosslin DR, et al. The cost of acute myocardial infarction in the new millennium: Evidence from a multinational registry. Am Heart J 2006;151:206-12.
15. Masoudi FA, Foody JM, Havranek EF, et al. Trends in acute myocardial infarction in 4 US states between 1992 and 2001: Clinical characteristics, quality of care, and outcomes. Circulation 2006;114:2806-14.
16. Boersma E. Does time matter? A pooled analysis of randomized clinical trials comparing primary percutaneous coronary intervention and in-hospital fibrinolysis in acute myocardial infarction patients. Eur Heart J 2006;27:779-88.
17. Stenestrand U, Lindbäck J, Wallentin L. Long-term outcome of primary percutaneous coronary intervention vs prehospital and in-hospital thrombolysis for patients with ST-elevation myocardial infarction. JAMA 2006;296:1749-56.
18. Bradley EH, Herrin J, Wang Y, et al. Strategies for reducing the door-to-balloon time in acute myocardial infarction. N Engl J Med 2006;355:2308-20.
19. Jollis JG, Roettig ML, Aluko AO, et al. Implementation of a statewide system for coronary reperfusion for ST-elevation myocardial infarction. JAMA 2007;298:2371-80.
20. Hulten E, Jackson JL, Douglas K, et al. The effect of early, intensive statin therapy on acute coronary syndrome: A meta-analysis of randomized controlled trials. Arch Intern Med 2006;166:1814-21.